EN
抗体药类似物
Research Grade Obiltoxaximab
All
TD-JN898016_1.jpg
TD-JN898016_2.jpg
TD-JN898016_3.jpg
  • CatalogTD-JN898016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsETI-204,CAS:1351337-07-9
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Obiltoxaximab


Catalog No. TD-JN898016
Species reactivity Bacillus anthracis
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Protective antigen, PA, Anthrax toxins translocating protein, PA-83, PA83, Protective antigen PA-20, PA-20, PA20, Protective antigen PA-63, PA-63, PA63, pagA, pag, pXO1-110, BXA0164, GBAA_pXO1_0164
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P13423
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ETI-204,CAS:1351337-07-9
Background Obiltoxaximab (ETI 204) is the second and potent anti-protective antigen (PA) monoclonal antibody with immunogenicity. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication, promoting survival, and inhibiting bacterial spread to the periphery in animal models. Obiltoxaximab can be used in the research of inhalational anthrax, bacteremia and toxemia.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-JN898016_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Obiltoxaximab.
TD-JN898016_2.jpg
Bioactivity
 
Detects PA/pagA/PA-83 in indirect ELISAs.
TD-JN898016_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Obiltoxaximab.